Lithuania drug industry growth

Lithuania's pharmaceutical industry recorded a healthy annual increasein sales of 38% last year, due to growth in both domestic and export markets, reports Baltic Business News.

Albertas Bertulis, president of the Lithuanian Association of Pharmaceutical Companies, estimates that the industry's sales totaled 104 million litas ($25.5 million) last year, which is substantially more than had been forecast, and he added that sales by the Association's 11 members are likely to increase a further 10%-20% this year.

According to the Association, Sanitas had the highest level of sales last year, at 24.5 million litas, followed by Biotechna, Ilsanta and Endocrine Preparations, with sales of 20.4 million litas, 16 million litas and 15.9 million litas, respectively.